Core Insights - Twin Disc, Incorporated (TWIN) is experiencing improved results driven by increasing end-market demand and new market opportunities [1] Group 1 - The company is characterized as a small industrial entity that is largely uncovered and has low liquidity in terms of average daily trading volume [1] - Management continues to focus on leveraging market trends to enhance performance [1]

Market Overview - The stock market experienced a mixed performance during the holiday-shortened week, with the Dow and Nasdaq declining by 0.1% and 1.5% respectively, while the S&P 500 fell approximately 1%, marking its third consecutive loss since Monday [1] - The S&P 500 had a strong performance in 2025, advancing over 16%, with the Nasdaq Composite and Dow Jones gaining 20% and 13% respectively, all reaching record highs during the year [1] Federal Reserve Insights - The Federal Reserve's December policy meeting minutes revealed a divided opinion among officials regarding a 25-basis-point rate cut, which was approved by a 9-3 vote, indicating the most dissent since 2019 [1] - The market's reaction to the Fed's decision was muted, with stocks continuing to decline despite the announcement [1] Company Performances Winners - **GE Vernova**: Increased by 98.7%, benefiting from the AI boom and strong quarterly earnings, with positive guidance through fiscal 2028 [1] - **Corning**: Rose by 84.3%, driven by strength in consumer electronics and a partnership with Apple, also benefiting from AI-related demand for specialty glass [1] - **Alphabet**: Gained 65.3%, with improved investor sentiment due to a robust AI roadmap and developments in its large language models [1] Laggards - **Salesforce**: Decreased by 20.8%, facing challenges from AI adoption that threatens its seat-based business model, leading to a downgrade to a hold-equivalent rating [1] - **Nike**: Fell by 15.8%, impacted by a decline in the China market and challenges in its direct-to-consumer strategy, despite insider buying signaling confidence [1] - **Procter & Gamble**: Dropped by 14.5%, affected by macroeconomic uncertainties and fears regarding costs due to changing rates and tariffs, though it remains a hedge against consumer spending pullbacks [1]

Group 1 - GE Vernova Inc. (NYSE:GEV) is an industrial machinery firm that has seen its shares increase by 95% year-to-date, with a notable 16% rise on December 10th following an updated revenue forecast for 2026 [2] - The company anticipates organic revenue growth of 16% to 18% and electrification revenue growth of 20% in 2026, with projected revenue between $41 billion and $42 billion, significantly higher than the 2025 forecast of $36 billion to $37 billion [2] - Following the investor update, Baird raised its price target for GE Vernova Inc. to $816 from $706, maintaining an Outperform rating, while Wells Fargo increased its target to $831 from $717, also keeping an Outperform rating [2] Group 2 - Jim Cramer has consistently praised GE Vernova Inc. for its potential in delivering nuclear power plants and has highlighted concerns regarding the reliance on natural gas turbines for electricity generation [3] - The company is positioned in a sector where there is a growing demand for high-voltage power solutions, which may impact its operational capabilities and market positioning [3]

Market Overview - The U.S. stock market experienced a slight decline on December 26, 2025, primarily due to low trading volume following the Christmas holiday, with many institutional investors absent for the year [1] - Major indexes such as the S&P 500, Dow, and Nasdaq saw small dips, ending short winning streaks observed earlier in the week [1][9] Investment Strategy - During the holiday season, equity investors may favor dividend-growth stocks over high price-growth stocks, as companies with a consistent history of dividend increases often exhibit strong financial health [2] - Dividend-growth stocks provide a defensive hedge against economic uncertainty and market volatility, making them attractive during periods of low market activity [4] Dividend Growth Stocks - Stocks with a strong history of year-over-year dividend growth are considered healthier investments, offering greater potential for capital appreciation compared to simple dividend-paying stocks [3][6] - Five selected dividend-growth stocks include: - Woodward Inc. (WWD): Expected revenue growth of 11.1% for fiscal 2026, long-term earnings growth rate of 15.20%, and an annual dividend yield of 0.36% [10] - Enersys (ENS): Projected revenue growth of 4% for fiscal 2026, long-term earnings growth rate of 15%, and an annual dividend yield of 0.70% [11] - Donaldson (DCI): Anticipated revenue growth of 3.5% for fiscal 2026, long-term earnings growth rate of 10%, and an annual dividend yield of 1.31% [12] - Rockwell Automation (ROK): Expected revenue growth of 5.8% for fiscal 2026, long-term earnings growth rate of 12.4%, and an annual dividend yield of 1.38% [13] - Vertiv Holdings (VRT): Projected revenue growth of 27.5% for fiscal 2025, long-term earnings growth rate of 30.2%, and an annual dividend yield of 0.15% [14] Stock Selection Criteria - Stocks selected for their strong fundamentals include criteria such as: - 5-Year Historical Dividend Growth Greater Than Zero [6] - 5-Year Historical Sales Growth Greater Than Zero [7] - 5-Year Historical EPS Growth Greater Than Zero [7] - Next 3-5 Year EPS Growth Rate Greater Than Zero [7] - Price/Cash Flow Less Than Industry Median [8] - 52-Week Price Change Greater Than S&P 500 [8]

Company Overview - Standex International Corporation is a mid-cap industrial manufacturer with a global footprint, operating through five specialized segments that address diverse commercial and industrial needs [6] - The company emphasizes innovation in engineered products and customization to serve demanding end markets, differentiating itself within the industrial machinery sector [6] Financial Performance - Standex reported trailing twelve-month (TTM) revenue of $837.07 million and net income of $52.62 million [4] - The adjusted operating margin expanded by 210 basis points year over year to 19.1%, while adjusted EBITDA climbed 38% to $47.1 million [11] - Sales jumped 27.6% year over year to $217.4 million, driven by acquisitions and accelerating demand in fast-growth end markets like electrical grid infrastructure, defense, aviation, and space [10] Market Position and Strategy - Standex's latest quarter saw record orders of $226 million, pushing the book-to-bill ratio above one, indicating strong forward revenue visibility [10] - The company generates revenue through the design, manufacture, and sale of specialized industrial products across five business segments, serving commercial and industrial customers globally [9] - Standex's broad product offering includes electronics sensors, custom transformers, mold texturizing, scientific refrigeration, engineered components for aerospace and defense, and specialty merchandising equipment [9] Investment Activity - Anchor Capital Management Company increased its position in Standex by 29,998 shares, bringing the total to 98,394 shares valued at $20.85 million as of September 30 [2][3] - Standex now constitutes 17.95% of Anchor Capital's 13F assets under management (AUM), making it the fund's second-largest position [3]

Company Overview - GE Vernova Inc. (NYSE:GEV) is an industrial machinery company primarily focused on power generation and nuclear power businesses [2]. Financial Outlook - Jefferies raised the share price target for GE Vernova Inc. to $815 from $736 and upgraded the rating to Buy, citing an impressive outlook for the power and electrification business [2]. - Recent share price declines were attributed to market sentiment regarding data centers [2]. Market Position - Jim Cramer highlighted GE Vernova as a leading company capable of delivering nuclear plants for data center construction, emphasizing its role in the power generation sector [2][3]. - GE Vernova is one of only three companies that manufacture natural gas generators, which are crucial for data center power needs [3]. Capacity and Supply Challenges - There are concerns regarding the capacity of natural gas generators, with current availability not expected until 2030, and a queue for orders extending to 2028 [3]. - The nuclear power situation is projected to be addressed by 2035, indicating a long-term timeline for expansion in this area [3].

Core Insights - Ingersoll Rand Inc. (IR) is experiencing increased orders across its industrial vacuums and blowers, leading to a 7.2% year-over-year growth in the Industrial Technologies & Services (IT&S) segment, totaling $1.52 billion in orders for Q3 2025 [1] - The Precision and Science Technologies segment reported an 11.1% year-over-year increase in orders, reaching $420.1 million, driven by strong momentum in the life sciences business and demand for biopharma solutions [2] - The company is actively expanding its portfolio through acquisitions, including Transvac Systems Ltd., Dave Barry Plastics, and Lead Fluid, which enhance its life sciences and engineered solutions offerings [3][4] Financial Performance - In the first nine months of 2025, Ingersoll Rand generated free cash flow of $758.6 million, a slight increase of 0.3% year over year, while returning $24 million in dividends and repurchasing $703 million in treasury stocks [5] - Acquisitions contributed 4.7% to total revenues in Q3 2025, reflecting the positive impact of strategic buyouts on financial performance [4] Cost and Debt Concerns - The company is facing rising operating costs, with the cost of sales increasing by 4.4% year over year in the first nine months of 2025, alongside a 5.6% rise in selling and administrative expenses in 2024 [9][10] - As of Q3 2025, Ingersoll Rand's long-term debt stood at $4.79 billion, with interest expenses of $65.1 million, marking a 2% increase year over year [11]

Summary of Perimeter Solutions Conference Call on M&A Announcement Company and Industry - **Company**: Perimeter Solutions (NYSE: PRM) - **Acquisition Target**: Medical Manufacturing Technologies LLC (MMT) - **Industry**: Medical Device Manufacturing Core Points and Arguments 1. **Acquisition Details**: Perimeter Solutions is acquiring MMT for $685 million in cash, which includes certain tax benefits. MMT is a leader in precision machinery for minimally invasive medical devices, expected to generate approximately $140 million in revenue and $50 million in EBITDA in 2025 [4][12][10]. 2. **Funding Structure**: The acquisition will be funded through $500 million of new senior secured debt financing and approximately $185 million of cash on hand. Post-acquisition, total debt is expected to be around $1.2 billion, with net debt just over $1 billion [4][12][13]. 3. **Operational Fit**: MMT aligns with Perimeter's operational pillars, focusing on high-quality industrial businesses, value driver operating strategy, and a decentralized structure. MMT's strong margins and growth potential are highlighted [5][6][8]. 4. **Market Trends**: The growth of MMT is driven by increasing adoption of minimally invasive procedures, device complexity, and machinery outsourcing. The installed base of MMT has grown at a CAGR of approximately 5% since 2016 [11][10]. 5. **Aftermarket Revenue**: Approximately 50% of MMT's revenue comes from aftermarket consumables and services, which are critical for customer compliance and quality management systems [10][11]. 6. **Regulatory Compliance**: MMT's products are specified in regulatory filings with the FDA, creating a competitive moat around the business [17][10]. 7. **Future Growth Opportunities**: There is potential for further acquisitions to broaden MMT's product suite, with a focus on tuck-in M&A to enhance customer offerings [26][28]. Additional Important Content 1. **Financial Metrics**: The acquisition price implies a purchase price multiple of approximately 14 times Adjusted EBITDA, which is considered attractive given the expected growth [12]. 2. **Capital Intensity**: MMT is expected to fit into Perimeter's relatively low capital intensity model, requiring only a few million dollars of CapEx against the projected $50 million of EBITDA [16]. 3. **Customer Relationships**: MMT has long-standing relationships with top customers, averaging 15 years, which enhances customer loyalty and revenue stability [10]. 4. **Decentralized Management**: MMT will operate as a standalone business within Perimeter's decentralized structure, allowing for operational autonomy and accountability [7][5]. 5. **Market Stability**: The end market for MMT's products is relatively steady, driven by the number of medical procedures, which supports long-term growth [24]. This summary encapsulates the key points discussed during the conference call regarding Perimeter Solutions' acquisition of MMT, highlighting the strategic fit, financial implications, and market dynamics.

Financial Performance Highlights - Fourth quarter sales reached $752 million, a 1% increase year-over-year, inclusive of divestiture[7] - Adjusted EPS for the fourth quarter was $3.03, a 9% increase year-over-year, hitting the high-end of guidance[7] - Fiscal year 2025 saw record sales of $2.8 billion, a 4% increase year-over-year[9] - Adjusted EPS for fiscal year 2025 increased by 5% year-over-year, exceeding the midpoint of earnings targets[9] - Record EBITDA of $900 million was achieved in fiscal year 2025[9, 35] Cash Flow and Capital Allocation - Record fourth quarter Free Cash Flow (FCF) of $194 million, resulting in a strong FCF conversion of 128%[7] - Fiscal year 2025 free cash flow reached $661 million, with a conversion rate of 136%[9, 42] - Approximately $300 million was allocated to share repurchases in fiscal year 2025[9] Segment Performance - Medical and Fluid Solutions (MFS) sales increased by 10% in the fourth quarter, reaching $220 million[22] - Industrial Precision Solutions (IPS) sales were $362 million, a decrease of 2%[17] - Advanced Technology Solutions (ATS) sales were $171 million, a decrease of 4%[28] Future Outlook - Fiscal year 2026 sales are projected to grow by 1% to 6%[53] - Adjusted earnings are expected to grow by 6% to 12% in fiscal year 2026[53]

Core Points - Graco Inc. has authorized a new plan to repurchase up to 15 million shares of its outstanding common stock [1] - The company currently has approximately 165.1 million shares outstanding [1] - The share repurchase will occur over an indefinite period or until the Board terminates the authorization [1]